Please login to the form below

Not currently logged in
Email:
Password:

Compassionate use programme

This page shows the latest Compassionate use programme news and features for those working in and with pharma, biotech and healthcare.

WHO trial casts doubt on remdesivir's efficacy

WHO trial casts doubt on remdesivir's efficacy

Gilead also revealed analyses from its compassionate use programme, which demonstrated that 83% of paediatric patients and 92% of pregnant and postpartum women with a broad spectrum of disease severity recovered ... Regeneron also recently announced that

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    compassionate use requests for the drug following an overwhelming demand for the drug. ... Although the compassionate use programme now only extends to children and pregnant women, Gilead said the ‘expanded access’ programme will allow hospitals or

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence. ... It also stressed that it is continuing to provide free medicines to the most seriously ill patients through its compassionate

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics